Nami Surgical raises £1.9 million and appoints Nikki Palfrey as CEO
Nami Surgical completed a £1.9 million investment round led by Eos Advisory and appointed medtech executive Nikki Palfrey as chief executive.
Evidence notes
- Eos Advisory led the round with participation from the Investment Fund for Scotland managed by Maven Capital Partners and Scottish Enterprise.
- The financing supports Nami's move from advanced development toward commercialisation of its miniaturised ultrasonic platform.
- Co-founder Nico Fenu moved to the COO role while co-founder Rebecca Cleary continued as CTO.
Company context
Nami Surgical develops miniaturised ultrasonic technology for robot-assisted and minimally invasive surgery. The Glasgow company is engineering compact surgical tools intended to improve precision and access in constrained anatomy while integrating with next-generation robotic platforms.